Pleuropulmonary blastoma (PPB) and other DICER1-associated high-grade malignancies are morphologically, genetically and epigenetically related - A comparative study of 4 PPBs and 6 sarcomas.


Journal

Annals of diagnostic pathology
ISSN: 1532-8198
Titre abrégé: Ann Diagn Pathol
Pays: United States
ID NLM: 9800503

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 23 04 2022
revised: 20 06 2022
accepted: 20 06 2022
pubmed: 3 7 2022
medline: 19 10 2022
entrez: 2 7 2022
Statut: ppublish

Résumé

DICER1-related tumors occur hereditary or sporadically, with high-grade malignancies sharing clinicopathological and (epi)genetic features. We compared 4 pleuropulmonary blastomas (PPBs) and 6 sarcomas by mutation analysis, whole transcriptome sequencing and methylation profiling. 9/10 patients were female. PPB patients were 0-4 years. 3/4 were alive; 2 without disease. One patient died of metastatic disease (median follow-up, 16 months). Sarcoma patients were 16-56 years. Locations included: uterine cervix/corpus (3/1), soft tissue back/shoulder (1) and paravertebral (1). 5/6 patients were alive; 2 developed metastases: intracranial (1) and lung and kidney (1) (median follow-up, 17 months). The deceased patient previously had a PPB and a Sertoli-Leydig cell tumor. Histologically, tumors showed atypical primitive-looking cells with incomplete rhabdomyoblastic differentiation and cartilage (n = 5). Immunohistochemistry demonstrated desmin- (n = 9/10), myogenin- (n = 6/10) and keratin positivity (n = 1/1). Eight cases harbored biallelic DICER1 mutations with confirmed germline mutations in 4 cases. Two cases showed a monoallelic mutation. By RNA expression- and methylation profiling, distinct clustering of our cases was seen demonstrating a close relationship on (epi)genetic level and similarities to embryonal rhabdomyosarcoma. In conclusion, this study shows overlapping morphological, immunohistochemical and (epi)genetic features of PPBs and DICER1-associated high-grade sarcomas, arguing that these neoplasms form a spectrum with a broad clinicopathological range.

Identifiants

pubmed: 35779311
pii: S1092-9134(22)00104-6
doi: 10.1016/j.anndiagpath.2022.152002
pii:
doi:

Substances chimiques

DEAD-box RNA Helicases EC 3.6.4.13
Desmin 0
DICER1 protein, human EC 3.1.26.3
Keratins 68238-35-7
Myogenin 0
Ribonuclease III EC 3.1.26.3
RNA 63231-63-0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

152002

Informations de copyright

Crown Copyright © 2022. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

L S Hiemcke-Jiwa (LS)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: L.S.Jiwa-3@prinsesmaximacentrum.nl.

S van Belle (S)

Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.

A Eijkelenboom (A)

Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.

J H M Merks (JHM)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

M M van Noesel (MM)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Division Imaging & Cancer, University Medical Center Utrecht, Utrecht, the Netherlands.

S E J Kaal (SEJ)

Department of Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.

J M A Pijnenborg (JMA)

Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands.

J Bulten (J)

Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.

B B J Tops (BBJ)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

C P van de Ven (CP)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

J M van Gorp (JM)

Department of Pathology, St Antonius Hospital, Nieuwegein, the Netherlands.

R R de Krijger (RR)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.

E Cheesman (E)

Department of Pathology, Central Manchester University Hospitals, Manchester, United Kingdom.

A M Kelsey (AM)

Department of Pathology, Central Manchester University Hospitals, Manchester, United Kingdom.

L A Kester (LA)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

U Flucke (U)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH